Alison Bass Speaking Tomorrow at GW

Alison Bass, an award-winning journalist and Pulitzer Prize nominee, will be here at George Washington University tomorrow to speak about why the system of drug research and development in the United States is seriously flawed and what reforms are needed.

Wednesday, March 18, 4:30pm
GWU-SPHHS Health Policy Department
2021 K St. NW, Ste. 800, Washington, DC
Sponsored by the EOH and Health Policy Departments

Bass is the author of Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial; copies will be available for purchase and signing at the event. The book tells the true story of two remarkable women who exposed the deception behind the marketing of bestselling antidepressant Paxil.

Also, whether or not you're in the DC area, Bass's blog is a great source of information on the problems associated with today's model of pharmaceutical marketing. For instance, check out her posts on the fraud case of anesthesiologist Dr. Scott Reuben;  the DOJ lawsuit against Forest Labs over their marketing of antidepressants Celexa and Lexapro; and Emory University's treatment of psychiatrist Dr. Charles Nemeroff, who had failed to disclose hundreds of thousands of dollars in personal payments from Paxil maker GlaxoSmith Kline.

More like this

DC-area readers, mark your calendars: Alison Bass, an award-winning journalist and Pulitzer Prize nominee, will be here at George Washington University on Wednesday, March 18th, to speak about why the system of drug research and development in the United States is seriously flawed and what reforms…
by Alison Bass (cross-posted) Martin Keller is finally stepping down as the long time chief of psychiatry at Brown University. Brown University officials made the announcement in a Dear Colleagues letter dated today from Edward J. Wing, Brown's new Dean of Medicine and Biological Sciences. While…
Bloggers are reacting to the news of major scientific fraud: Massachusetts anesthesiologist Dr. Scott Reuben falsified data in his published studies for more than a decade. Janet Stemwedel at Adventures in Ethics and Science explores the effects of Dr. Reubenâs duplicity on anesthesiology and…
Yesterday, The New York Times reported on the latest prominent medical doctor to be outed for not reporting the vast sums of money he was receiving from drug companies: One of the nation's most influential psychiatrists earned more than $2.8 million in consulting arrangements with drug makers from…